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Baltimore, MdTABLE 1. Study subject demographics (treated n¼ 21, resected n¼ 15)
Age (y, mean and range) 61.3 (38–82)
Female (no.) 10 (47.6%)
Time from cryotherapy to resection
(no., actual with intent to resect)
<1 d 5 (6)
1–3 d 2 (3)
5–7 d 3 (5)
8–106 d 5 (7)
Diagnosis for resection (no.)
Non–small cell lung cancer 18 (85.7%)
Small cell lung cancer 1 (4.8%)
Carcinoid tumor 1 (4.8%)
Recurrent mycobacterial infection 1 (4.8%)
Other diagnosesTraditional approaches to managing occluded airways include
surgery,mechanical debulking, brachytherapy, stents, photody-
namic therapy, and thermal modalities, such as electrocautery,
laser, argon plasma coagulation, and cryotherapy. Although
cryotherapywith cryoprobes has been used safely for over a de-
cade in airways management, it is often tedious and time-con-
suming because of surface area limitations of the probes,
which must be inserted into or come in contact with the surface
of the targeted lesion. Newer cryotherapy devices obviate the
need for contact with the target tissue. Reports of promising
results from use of low-pressure spray cryotherapy for ablation
of esophageal lesions1-2 have led to the experience reported
here, in which spray cryotherapy with low-pressure liquid
nitrogen was used for the first time to treat human airways.
Chronic obstructive pulmonary disease 8
Asthma 6
Chronic bronchitis 2
Recurrent bronchitis 2
Bronchiectasis 2
Diabetes 2
Coronary artery disease 3
Heart disease 1
History of myocardial infarction 1
Hepatitis C 2
Esophageal cancer 1
Laryngeal cancer 1
Breast cancer 1
Hypertension 1
Poliomyelitis 1
Peripheral neuropathy 1
Rheumatoid arthritis 1
Anxiety or depression 1CLINICAL SUMMARY
After provision of informed consent, spray cryotherapy
with liquid nitrogen was performed on 21 subjects (Table
1) with the CryoSpray Ablation System (CSA Medical, Inc,
Baltimore, Md) during standard bronchoscopy in anticipation
of lung resection. Subjects were placed on 100% oxygen and
ventilation through an endotracheal tube for maximal subject
airway control in accordance with institutional guidelines. A
7F cryocatheter was introduced through the working channel
of a therapeutic flexible, videobronchoscope (Olympus BF-
X1T160 or BF-X1T180; Olympus America Inc, Center Val-
ley, Pa) and extended 1 cm beyond the tip. A permanent dye
marker (GIS-44; GI Supply, Camp Hill, Pa) was injected
proximal to the intended treatment area at the takeoff of the
segmental or lobar bronchus being treated to demarcate the
treatment site. All sites received a targeted delivery of low-
pressure (2–3 psi) liquid nitrogen of identical dosimetry, 2 cy-
cles of 5-second spraywith a 60-second interim thaw.Oxygen
saturation and peak airway pressure were monitored con-From the Pulmonary and Critical Care Department,a Surgical Pathology,b and the
Thoracic Surgery Department,c Franklin Square Hospital Center, Baltimore, Md.
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The Journal of Thoracic and Castantly. All patients had treatment times shorter than 5 min-
utes. Bronchoscopic and histologic examinations of airways
were conducted at various times, ranging from less than 1
day to 106 days after treatment. Postprocedural pain scores
were assessed with a visual analog scale 24 hours after the
procedure and 1 day before the scheduled resection.
Six of the 21 patients did not undergo surgical resection be-
cause of intraoperative findings. Histologic inspection of the
resected specimens was performed at 250-mm intervals by
two pathologists (J.N.B.) blinded to specimen origin. They
noted the number of slides showing any changes andwhere ap-
plicable the percentage of airway smooth muscle that was af-
fected (Table 2). Findings from the treated areas revealed
varying levels of cryonecrosis, limited to the mucosal andrdiovascular Surgery c Volume 139, Number 3 781
TABLE 2. Main histologic findings in sections of treated airway tissue
Other observed changes
Time to
resection
Total
sections
Airway
sections with
changes
Altered
CASM Epithelium
Submucosal
glands Cartilage Parenchyma
<1 d 25 18 (72%) 18%–64% Extensive sloughing
(16 sections), focal
sloughing (2 sections)
Recent injury (9 sections),
minimal regenerative
changes (9 sections)
No significant change
(25 sections)
No significant change
(25 sections)
2 d 12 10 (83%) 5%–60% Sloughing (10 sections),
regenerative changes
(10 sections),
squamous metaplasia
(4 sections)
Moderate regenerative
changes (10 sections)
No significant change
(12 sections)
No significant change
(12 sections)
6.3 d 20 11 (55%) 33%–56.7% Sloughing (11 sections),
squamous metaplasia
(11 sections), regenerative
changes (1 section),
appearance of normal
(10 sections)
Mild (4 sections) to
moderate (6 sections)
regenerative changes
No significant change
(20 sections)
No significant change
(20 sections)
37 d 31 25 (81%) 5%–27.5% Sloughing (8 sections),
regenerative changes
(14 sections), squamous
metaplasia (2 sections),
normal epithelium
(23 sections)
Mild (6 sections)
to extensive (8 sections)
regenerative changes,
return to normal
(11 sections)
No significant change
(31 sections)
No significant change
(31 sections)
Groups are according to mean time between cryotherapy and resection. Histologic assessments on serial sections are reported for each group. Because of tissue heterogeneity,
sections were deemed positive for findings noted anywhere on section and are described as mild, moderate, extensive, or no significant change where possible. Ranges shown
are means of ranges determined for each group of subjects. CASM, Circumferential airway smooth muscle (showing any change).
Brief Technique Reportssubmucosal layers (approximately 1.5 mm), and changes con-
sistent with recent tissue injury with no damage to connective
tissue. Loss of epithelium and airway smooth muscle, edema,
and damaged submucosal glands observed at early time points
were followed by adjacent re-epithelialization and healing cen-
trally from the margin of the injury. Complete re-epithelializa-
tion of the airway mucosa and a thinned or absent smooth
muscle layer, aswell as some continued thinning of the submu-
cosal glands, were persistent to 106 days after treatment.
Neither any adverse events nor any unanticipated side effects
occurred with any of the procedures. No exacerbations were re-
corded for subjectswith comorbidities suchas asthmaor chronic
bronchitis.Themeanpainscore,as reportedaccordingtoavisual
analog scale of 0 to 10, was 2.9. There was no evidence of scar-
ring, and bronchoscopic evaluation 12months after treatment of
3 patients who did not undergo resection was unremarkable.
DISCUSSION
This report demonstrates the safety and feasibility of apply-
ing spray cryotherapy in the human airway. Unlike the cryo-
probe (86C), spray cryotherapy with liquid nitrogen
(196C) is a noncontact method of tissue ablation, can be
used to treat larger areas quickly, and provides more uniform
treatment. This choice of cryogen and method of delivery cre-
ates an almost instantaneous freezing of the target tissue,which
may result in greater depth andmore complete cellular injury.3
The lack of uniform contact with the cryoprobe and the varia-782 The Journal of Thoracic and Cardiovascular Surgtions in the isotherms as distance from the cryoprobe increases
lead to incomplete tissue injury, which may pose problems.4-5
Recent reports of spray cryotherapy to treat Barrett esoph-
agus, dysplasia, and esophageal cancers1-2 are promising.
The mucosal epithelium of treated esophageal tissue
regenerates without scarring, similar to our results in the air-
ways. Our initial safety and histologic assessments suggest
that spray cryotherapy may be safe and conducive to treat-
ment of airway obstructions by causing focal injury to the cel-
lular elements of treated tissue without damage to underlying
connective tissue. Although the study included only a small
number of subjects and normal, unobstructed airways were
treated, regeneration of histologically normal epithelium,
with the evident loss or thinning of airway smooth muscle
and a decrease in the glandular content of the mucosa, sug-
gest treatment possibilities in other human thoracic diseases.
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